- Home
- NERV vs GLXG Comparison
NERV vs GLXG Comparison
Compare NERV & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- GLXG
- Stock Information
- Founded
- NERV 2007
- GLXG 2013
- Country
- NERV United States
- GLXG Hong Kong
- Employees
- NERV N/A
- GLXG N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- GLXG
- Sector
- NERV Health Care
- GLXG
- Exchange
- NERV Nasdaq
- GLXG NYSE
- Market Cap
- NERV 12.4M
- GLXG 11.1M
- IPO Year
- NERV 2014
- GLXG 2024
- Fundamental
- Price
- NERV $1.84
- GLXG $0.55
- Analyst Decision
- NERV Hold
- GLXG
- Analyst Count
- NERV 1
- GLXG 0
- Target Price
- NERV $5.00
- GLXG N/A
- AVG Volume (30 Days)
- NERV 15.2K
- GLXG 73.0K
- Earning Date
- NERV 08-05-2025
- GLXG 06-17-2025
- Dividend Yield
- NERV N/A
- GLXG N/A
- EPS Growth
- NERV N/A
- GLXG N/A
- EPS
- NERV 0.83
- GLXG N/A
- Revenue
- NERV N/A
- GLXG $3,711,233.00
- Revenue This Year
- NERV N/A
- GLXG N/A
- Revenue Next Year
- NERV N/A
- GLXG N/A
- P/E Ratio
- NERV $2.23
- GLXG N/A
- Revenue Growth
- NERV N/A
- GLXG N/A
- 52 Week Low
- NERV $1.15
- GLXG $0.52
- 52 Week High
- NERV $3.69
- GLXG $16.93
- Technical
- Relative Strength Index (RSI)
- NERV 65.83
- GLXG N/A
- Support Level
- NERV $1.75
- GLXG N/A
- Resistance Level
- NERV $1.90
- GLXG N/A
- Average True Range (ATR)
- NERV 0.12
- GLXG 0.00
- MACD
- NERV 0.04
- GLXG 0.00
- Stochastic Oscillator
- NERV 90.00
- GLXG 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.